Nevada dmv traffic safety quick tips - lane departures
Lane Departures Who is at risk?
Head-on collisions and other types of lane depar-
ture crashes can happen to anyone at any time. But
Crashes that begin with the vehicle running off the
specifi c groups most at risk include males age 26
pavement or otherwise departing from the lane of
to 35, drivers on rural roads and those on the road
travel are a leading cause of fatal crashes.
between 3 a.m. and 6 a.m. Saturday and Sunday
Drivers tend to jerk the wheel or “overcorrect” to get
are the most dangerous days of the week for lane
back onto the road. The vehicle will careen across
the highway into oncoming traffi c or the driver will
overcorrect again and the vehicle may roll over. Road Improvements
The Nevada Department of Transportation is mak-
ing improvements on state roadways to help combat
Rumble Strips The Off/Off Rule
Keep your foot off the accelerator and off the brakes
if your vehicle has run off the pavement.
• Don’t panic! Ease off on the accelerator. Don’t use
the brakes unless you’re headed for an obstacle.
• Gently steer the vehicle parallel to the road. Con-
tinue to slow down. In extreme cases, it may be
safer to keep going straight until you can stop.
• Check for traffi c approaching in the lane you will
• Gently ease the wheels onto the pavement. Cable Barriers
• Straighten into the fi rst lane and speed up to the
Avoid Drowsy Driving What Works
• Get adequate sleep - Schedule your work and plan
your trip to give yourself the time to sleep.
• Stop - Find a safe place to stop for some good
sleep such as motel, rest area, friend’s house, etc.
• Nap, then Stop - If you are not near a safe stop,
a 20-minute nap can help you stay alert long
• Caffeine - Two cups of strong coffee or the equiva-
Fender Bender? Move Over
You must move the vehicle to a location that does
not obstruct traffi c if there are no injuries, your
What Doesn’t Work
vehicle is obstructing traffi c and the vehicle can be
are no substitute for adequate rest.
Laura Locatelli. Caso di positività del test antidoping effettuato in occasione del Campionato Europeo Master di Pilsen il 17.7.2012 In data 17 agosto 2012 la FIPL riceveva un avviso di “adverse analytical finding” (“non negatività”) del test in oggetto. Il referto circa la molecola rintracciata nel campione di urina analizzato presso il Laboratorio WADA di Colonia, riport
September MIMS Monthly Medicine Update NEW PRODUCTS Priligy (dapoxetine hydrochloride) Zaltrap (aflibercept (rch)) is a Erivedge (vismodegib) is a low severe chronic neutropenia (SCN); and in endothelial growth factor (VEGF) receptor (1 and 2) extracellular domains fused to HIV therapy. Zarzio is contraindicated in ejaculatory latency time (IELT) of less than patients with kn
Lane Departures